Literature DB >> 22245778

Engineering human MEK-1 for structural studies: A case study of combinatorial domain hunting.

Christoph Meier1, Daniel C Brookings, Thomas A Ceska, Carl Doyle, Haiping Gong, David McMillan, Giles P Saville, Adeel Mushtaq, David Knight, Stefanie Reich, Laurence H Pearl, Keith A Powell, Renos Savva, Rodger A Allen.   

Abstract

Structural biology studies typically require large quantities of pure, soluble protein. Currently the most widely-used method for obtaining such protein involves the use of bioinformatics and experimental methods to design constructs of the target, which are cloned and expressed. Recently an alternative approach has emerged, which involves random fragmentation of the gene of interest and screening for well-expressing fragments. Here we describe the application of one such fragmentation method, combinatorial domain hunting (CDH), to a target which historically was difficult to express, human MEK-1. We show how CDH was used to identify a fragment which covers the kinase domain of MEK-1 and which expresses and crystallizes significantly better than designed expression constructs, and we report the crystal structure of this fragment which explains some of its superior properties. Gene fragmentation methods, such as CDH, thus hold great promise for tackling difficult-to-express target proteins. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22245778     DOI: 10.1016/j.jsb.2012.01.002

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  9 in total

1.  Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in Cancer.

Authors:  Aphrothiti J Hanrahan; Brooke E Sylvester; Matthew T Chang; Arijh Elzein; Jianjiong Gao; Weiwei Han; Ye Liu; Dong Xu; Sizhi P Gao; Alexander N Gorelick; Alexis M Jones; Amber J Kiliti; Moriah H Nissan; Clare A Nimura; Abigail N Poteshman; Zhan Yao; Yijun Gao; Wenhuo Hu; Hannah C Wise; Elena I Gavrila; Alexander N Shoushtari; Shakuntala Tiwari; Agnes Viale; Omar Abdel-Wahab; Taha Merghoub; Michael F Berger; Neal Rosen; Barry S Taylor; David B Solit
Journal:  Cancer Res       Date:  2020-07-08       Impact factor: 12.701

2.  Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer.

Authors:  Yuji Kubota; Yuko Fujioka; Ashwini Patil; Yusuke Takagi; Daisuke Matsubara; Masatomi Iijima; Isao Momose; Ryosuke Naka; Kenta Nakai; Nobuo N Noda; Mutsuhiro Takekawa
Journal:  Nat Commun       Date:  2022-07-13       Impact factor: 17.694

Review 3.  Library methods for structural biology of challenging proteins and their complexes.

Authors:  Darren J Hart; Geoffrey S Waldo
Journal:  Curr Opin Struct Biol       Date:  2013-04-17       Impact factor: 6.809

4.  Fragment-Based Discovery of Novel Allosteric MEK1 Binders.

Authors:  Paolo Di Fruscia; Fredrik Edfeldt; Igor Shamovsky; Gavin W Collie; Anna Aagaard; Louise Barlind; Ulf Börjesson; Eva L Hansson; Richard J Lewis; Magnus K Nilsson; Linda Öster; Josefine Pemberton; Lena Ripa; R Ian Storer; Helena Käck
Journal:  ACS Med Chem Lett       Date:  2021-01-27       Impact factor: 4.345

5.  Cytotoxic Effect of Vanicosides A and B from Reynoutria sachalinensis Against Melanotic and Amelanotic Melanoma Cell Lines and in silico Evaluation for Inhibition of BRAFV600E and MEK1.

Authors:  Izabela Nawrot-Hadzik; Anna Choromańska; Renata Abel; Robert Preissner; Jolanta Saczko; Adam Matkowski; Jakub Hadzik
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

6.  Neural relational inference to learn long-range allosteric interactions in proteins from molecular dynamics simulations.

Authors:  Jingxuan Zhu; Juexin Wang; Weiwei Han; Dong Xu
Journal:  Nat Commun       Date:  2022-03-29       Impact factor: 14.919

7.  How oncogenic mutations activate human MAP kinase 1 (MEK1): a molecular dynamics simulation study.

Authors:  Ye Liu; Jingxuan Zhu; Xiaoqing Guo; Tianci Huang; Jiarui Han; Jianjiong Gao; Dong Xu; Weiwei Han
Journal:  J Biomol Struct Dyn       Date:  2019-11-06

8.  ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system.

Authors:  Sigrun Polier; Rahul S Samant; Paul A Clarke; Paul Workman; Chrisostomos Prodromou; Laurence H Pearl
Journal:  Nat Chem Biol       Date:  2013-03-17       Impact factor: 15.040

9.  Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.

Authors:  Stelios Chrysostomou; Rajat Roy; Filippo Prischi; Lucksamon Thamlikitkul; Kathryn L Chapman; Uwais Mufti; Robert Peach; Laifeng Ding; David Hancock; Christopher Moore; Miriam Molina-Arcas; Francesco Mauri; David J Pinato; Joel M Abrahams; Silvia Ottaviani; Leandro Castellano; Georgios Giamas; Jennifer Pascoe; Devmini Moonamale; Sarah Pirrie; Claire Gaunt; Lucinda Billingham; Neil M Steven; Michael Cullen; David Hrouda; Mathias Winkler; John Post; Philip Cohen; Seth J Salpeter; Vered Bar; Adi Zundelevich; Shay Golan; Dan Leibovici; Romain Lara; David R Klug; Sophia N Yaliraki; Mauricio Barahona; Yulan Wang; Julian Downward; J Mark Skehel; Maruf M U Ali; Michael J Seckl; Olivier E Pardo
Journal:  Sci Transl Med       Date:  2021-07-14       Impact factor: 17.956

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.